TNF and rheumatic disorder: Similarly, in a large cohort of 5224 patients with rheumatic diseases evaluated before TNF inhibitor therapy, positive rates for TST, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB were 29, 17, and 18%, respectively, with concordance levels between 73 and 75%.